ASAPF (Aurora Spine) 1-Year Sharpe Ratio: -0.65 (As of Jul. 05, 2026)


ASAPF Aurora Spine Corp ASAPF
39 GF Score
Price $0.17
GF Value $0.21
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Aurora Spine 1-Year Sharpe Ratio?

Aurora Spine ASAPF -4.29% 39 1-Year Sharpe Ratio is -0.65 as of Jul. 05, 2026. GuruFocus rates ASAPF with a GF Score™ of 39/100 and a GF Value™ of $0.21 (Possible Value Trap). The stock has 4 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-05), Aurora Spine's 1-Year Sharpe Ratio is -0.65.

Aurora Spine  (OTCPK:ASAPF) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Aurora Spine 1-Year Sharpe Ratio Related Terms

ASAPF vs ABT, SYK, MDT: 1-Year Sharpe Ratio Comparison

For the Medical Devices subindustry, Aurora Spine's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aurora Spine 1-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Aurora Spine's 1-Year Sharpe Ratio falls into.


ASAPF
39GF Score
Aurora Spine Corp ASAPF
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aurora Spine 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -0.65 mean?
Aurora Spine (ASAPF) has a 1-Year Sharpe Ratio of -0.65 as of Jul. 05, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Aurora Spine and its competitors.
Is Aurora Spine's 1-Year Sharpe Ratio too high?
Aurora Spine's current 1-Year Sharpe Ratio is -0.65. Overall, Aurora Spine has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's 1-Year Sharpe Ratio compare to ABT and SYK?
Aurora Spine's 1-Year Sharpe Ratio of -0.65 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Devices & Instruments company?
A good 1-Year Sharpe Ratio depends on the Medical Devices & Instruments industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Aurora Spine and its competitors. Aurora Spine's current 1-Year Sharpe Ratio is -0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.21, compared to a current price of $0.17 — trading 20.2% below its estimated fair value. The current 1-Year Sharpe Ratio is -0.65. Aurora Spine's overall GF Score™ is 39/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current 1-Year Sharpe Ratio is -0.65 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aurora Spine (ASAPF) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued. The current stock price of $0.17 is trading 20.2% below its estimated GF Value™ of $0.21. GuruFocus considers Aurora Spine to be Possible Value Trap.

Key valuation signals for ASAPF:

  • 1-Year Sharpe Ratio: -0.65
  • GF Value™: $0.21 vs. price of $0.17 (20.2% below fair value)
  • GF Score™: 39/100 with 4 warning signs

No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Spine Business Description

Other Exchanges ASG:Canada
Address 20 Holly Street, Suite 300, Toronto, ON, CAN, M4S 3B1
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
39GF Score

Get the complete analysis for ASAPF

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.17
Price
$0.21
GF Value